Received Apr 27, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 3 | — | — |
No additional AE/ No PQC reported; administration of 3rd dose of ROTATEQ to a patient who is older than 32 weeks of age; This spontaneous report was received from a/an Physician and refers to an infant patient of unknown gender (reported as over 32 weeks). The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-Apr-2026, the patient, who was older than 32 weeks of age, received the third dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), 2 mL (lot # and expiration date were not reported) for prophylaxis (Product administered to patient of inappropriate age). No symptoms were reported.